Early response and genetics define relapse risk after frontline blinatumomab in childhood B-ALL: a cohort study. // Blood Advances. – URL: https://www.sciencedirect.com/science/article/pii/S247395292600621X?dgcid=rss_sd_all
Early response and genetics define relapse risk after frontline blinatumomab in childhood B-ALL: a cohort study. Blood Advances. https://www.sciencedirect.com/science/article/pii/S247395292600621X?dgcid=rss_sd_all
“Early response and genetics define relapse risk after frontline blinatumomab in childhood B-ALL: a cohort study.” Blood Advances.
@article{article106852,
title = {Early response and genetics define relapse risk after frontline blinatumomab in childhood B-ALL: a cohort study},
journal = {Blood Advances},
url = {https://www.sciencedirect.com/science/article/pii/S247395292600621X?dgcid=rss_sd_all}
}